Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial
- 1 July 2000
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 36 (1), 88-97
- https://doi.org/10.1053/ajkd.2000.8276
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextransAmerican Journal of Kidney Diseases, 1999
- Intravenous iron supplementation in end-stage renal disease patientsAmerican Journal of Kidney Diseases, 1999
- The safety of intravenous iron dextran in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996
- Safety of intravenous injection of iron saccharate in haemodialysis patientsNephrology Dialysis Transplantation, 1996
- 'Oversaturation' of transferrin after intravenous ferric gluconate (FerrlecitR) in haemodialysis patientsNephrology Dialysis Transplantation, 1996
- Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysisAmerican Journal of Kidney Diseases, 1996
- Injectable Medications for Hemodialysis PatientsAmerican Journal of Nephrology, 1996
- RACTICAL GUIDELINES FOR DRUG THERAPY IN DIALYSIS George R. Aronoff, Series Editor: Iron Dextran in Chronic Renal FailureSeminars in Dialysis, 1991
- Serum Sickness from Iron-Dextran AdministrationActa Haematologica, 1990
- Allergic Purpura following Intravenous Administration of lron DextranActa Haematologica, 1979